Fundamental Analysis · Last Quarter

FA

A dedicated fundamental analysis might help you to get a quick overview of the financial stability. However it is important to understand the FA Algorithm and the criterias before valuing it as a solution.

See FA Rationale
Framework:
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -93.70 27.22 431.82
Graham Fair Price 6.27 7.68 7.23
PEG 42.69 0.44 -0.31
Price/Book 7.44 1.31 1.22
Price/Cash Flow 97.07 -370.90 -12639.07
Prices/Earnings -10.54 7.58 8.47
Price/Sales 4.82 54.41 51.91
Price/FCF 97.07 -370.90 -12639.07
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 36.98 0.28 0.21
Operating Margin 3140.30 1.96 -0.06
ROA 18.00 0.03 0.03
ROE 0.04 0.04 20.10
ROIC < 0.005 0.04 3686.58
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.12 < 0.005 1529.39
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -1.02 33.20 3140.22
EPS QOQ -0.28 0.17 -37.30
FCF QOQ -1.00 -34.50 -3333.58
Revenue QOQ 0.10 < 0.005 -93.91
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 81.78 95.84 17.20
Days Sales Outstanding (DSO) 156.07 128.58 -17.61
Inventory Turnover 1.10 0.94 -14.67
Debt/Capitalization 0.12 0.14 20.10
Quick Ratio 2.31 1.34 -42.06
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 8.03 7.79 -3.02
Cash 0.74 0.81 9.02
Capex -0.04 -0.03 37.46
Free Cash Flow < 0.005 -0.03 -3450.34
Revenue 0.19 0.19 -0.61
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.64 1.54 -41.72
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 22.45 1.54 -93.13
Naive Interpretation Member
06 - Financial Health · Weak
Rating